Fund shareholders of Regeneron Pharmaceuticals, Inc.
ISIN US75886F1075 · United States · LEI 549300RCBFWIRX3HYQ56
- Fund shareholders
- 1,130
- Of which ETFs
- 315 815 other funds
- Value held
- 30.8B $ 4.1B SEK · 102.9M €
1,130 funds hold this company. This table lists the 1,113 that declare it in a regulatory filing. The other 17 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| DWS Core Equity Fund DEUTSCHE DWS INVESTMENT TRUST | 56,813 | 43.9M $ | 1.00 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Large Company ETF SCHWAB STRATEGIC TRUST | 55,382 | 43.3M $ | 0.18 % | as of Feb 28, 2026 ↗ |
| Federated Hermes MDT Large Cap Growth Fund Federated Hermes MDT Series | 54,967 | 38.9M $ | 0.75 % | as of Apr 30, 2026 ↗ |
| NEOS Nasdaq-100(R) High Income ETF NEOS ETF Trust | 53,482 | 41.3M $ | 0.44 % | as of Mar 31, 2026 ↗ |
| VANGUARD FTSE SOCIAL INDEX FUND VANGUARD WORLD FUND | 53,084 | 41.5M $ | 0.17 % | as of Feb 28, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 52,768 | 37.3M $ | 0.04 % | as of Apr 30, 2026 ↗ |
| Swedbank Robur Aktiefond Pension Swedbank Robur Fonder AB | 52,500 | 386.4M SEK | 0.36 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 52,349 | 37M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 52,124 | 36.9M $ | 1.32 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs U.S. Tax-Managed Equity Fund Goldman Sachs Trust | 51,920 | 40.1M $ | 0.97 % | as of Mar 31, 2026 ↗ |
| JNL/Mellon Nasdaq 100 Index Fund JNL Series Trust | 51,600 | 39.9M $ | 0.45 % | as of Mar 31, 2026 ↗ |
| Nuveen Growth Opportunities ETF NuShares ETF Trust | 50,872 | 36M $ | 1.27 % | as of Apr 30, 2026 ↗ |
| Multi-Manager Large Cap Growth Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 50,399 | 38.9M $ | 0.84 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 70 Swedbank Robur Fonder AB | 50,200 | 369.5M SEK | 0.38 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 49,992 | 38.6M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Stock Selector Large Cap Value Fund Fidelity Devonshire Trust | 48,500 | 34.3M $ | 0.22 % | as of Apr 30, 2026 ↗ |
| iShares Global Healthcare ETF iShares Trust | 48,287 | 37.3M $ | 1.03 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Marketwide Value ETF Dimensional ETF Trust | 48,000 | 33.9M $ | 0.24 % | as of Apr 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 47,616 | 33.7M $ | 1.18 % | as of Apr 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 47,000 | 36.3M $ | 5.46 % | as of Mar 31, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 46,894 | 36.2M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - S&P 500 Index Account College Retirement Equities Fund | 46,493 | 35.9M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 46,400 | 36.3M $ | 0.11 % | as of Feb 28, 2026 ↗ |
| Balanced Fund John Hancock Investment Trust | 45,382 | 32.1M $ | 0.49 % | as of Apr 30, 2026 ↗ |
| Victory Nasdaq-100 Index Fund Victory Portfolios III | 44,611 | 31.5M $ | 0.36 % | as of Apr 30, 2026 ↗ |
| LORD ABBETT AFFILIATED FUND INC LORD ABBETT AFFILIATED FUND INC | 44,337 | 31.3M $ | 0.47 % | as of Apr 30, 2026 ↗ |
| SOUND SHORE FUND SOUND SHORE FUND, INC. | 44,045 | 34M $ | 3.70 % | as of Mar 31, 2026 ↗ |
| First Trust Nasdaq-100 Select Equal Weight ETF First Trust Exchange-Traded Fund | 43,693 | 33.8M $ | 2.15 % | as of Mar 31, 2026 ↗ |
| Global X NASDAQ 100 Covered Call ETF GLOBAL X FUNDS | 43,487 | 30.7M $ | 0.37 % | as of Apr 30, 2026 ↗ |
| AST Large-Cap Value Portfolio Advanced Series Trust | 43,408 | 33.5M $ | 0.90 % | as of Mar 31, 2026 ↗ |
| Focused Appreciation Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 43,393 | 33.5M $ | 2.46 % | as of Mar 31, 2026 ↗ |
| Six Circles Managed Equity Portfolio U.S. Unconstrained Fund SIX CIRCLES TRUST | 43,177 | 33.4M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| JNL/Mellon Healthcare Sector Fund JNL Series Trust | 43,156 | 33.3M $ | 1.31 % | as of Mar 31, 2026 ↗ |
| Pacer US Large Cap Cash Cows Growth Leaders ETF Pacer Funds Trust | 43,095 | 30.5M $ | 1.40 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 43,042 | 30.4M $ | 0.08 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra QQQ ProShares Trust | 42,524 | 33.2M $ | 0.34 % | as of Feb 28, 2026 ↗ |
| Longleaf Partners Global Fund Longleaf Partners Funds Trust | 41,304 | 31.9M $ | 4.83 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Value Index Fund Fidelity Salem Street Trust | 41,276 | 29.2M $ | 0.22 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Market Neutral Fund Federated Hermes Adviser Series | 40,465 | 31.3M $ | 1.39 % | as of Mar 31, 2026 ↗ |
| Six Circles U.S. Unconstrained Equity Fund SIX CIRCLES TRUST | 39,654 | 30.6M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 39,455 | 30.5M $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Value Index Fund TIAA-CREF Funds | 39,141 | 27.7M $ | 0.22 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT All Cap Core Fund Federated Hermes MDT Series | 38,984 | 27.6M $ | 0.80 % | as of Apr 30, 2026 ↗ |
| VOYA GROWTH AND INCOME PORTFOLIO Voya Variable Funds | 37,674 | 29.1M $ | 1.21 % | as of Mar 31, 2026 ↗ |
| State Street Equity 500 Index II Portfolio STATE STREET INSTITUTIONAL INVESTMENT TRUST | 36,942 | 28.5M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Victory Growth Fund Victory Portfolios III | 36,403 | 25.7M $ | 1.06 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 36,132 | 27.9M $ | 7.51 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 36,004 | 25.5M $ | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Large Cap Value Index Fund Fidelity Salem Street Trust | 35,249 | 24.9M $ | 0.22 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 33,791 | 26.4M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| JPMorgan Hedged Equity 2 Fund JPMorgan Trust IV | 33,658 | 26M $ | 0.48 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Quality Factor ETF J.P. Morgan Exchange-Traded Fund Trust | 33,107 | 23.4M $ | 0.31 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 32,989 | 23.3M $ | 0.06 % | as of Apr 30, 2026 ↗ |
| Value Portfolio PACIFIC SELECT FUND | 32,799 | 25.3M $ | 1.86 % | as of Mar 31, 2026 ↗ |
| iShares MSCI ACWI ETF iShares Trust | 32,592 | 23M $ | 0.07 % | as of Apr 30, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 32,335 | 22.9M $ | 2.02 % | as of Apr 30, 2026 ↗ |
| Schwab 1000 Index Fund SCHWAB INVESTMENTS | 32,214 | 22.8M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| VIP Index 500 Portfolio Variable Insurance Products Fund II | 31,814 | 24.6M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Large Cap Core ETF Fidelity Covington Trust | 31,547 | 24.4M $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Large Cap Value Fund Federated Hermes Adviser Series | 31,067 | 22M $ | 0.94 % | as of Apr 30, 2026 ↗ |
| Voya Large Cap Growth Portfolio Voya Investors Trust | 30,722 | 23.7M $ | 0.75 % | as of Mar 31, 2026 ↗ |
| AB RELATIVE VALUE FUND, INC. AB RELATIVE VALUE FUND, INC. | 30,623 | 21.7M $ | 1.16 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Large Cap Core Fund BlackRock Large Cap Series Funds, Inc. | 30,227 | 23.6M $ | 0.67 % | as of Feb 27, 2026 ↗ |
| Stock Index Fund Northern Funds | 30,123 | 23.3M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 29,714 | 21M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 28,864 | 22.6M $ | 0.10 % | as of Feb 28, 2026 ↗ |
| Putnam Core Equity Fund Putnam Funds Trust | 28,762 | 20.3M $ | 0.33 % | as of Apr 30, 2026 ↗ |
| JNL/Mellon S&P 500 Index Fund JNL Series Trust | 28,711 | 22.2M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Domestic Equity Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 28,455 | 22M $ | 1.89 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 80 Swedbank Robur Fonder AB | 28,000 | 206.1M SEK | 0.21 % | as of Mar 31, 2026 ↗ |
| Virtus Ceredex Mid-Cap Value Equity Fund Virtus Asset Trust | 28,000 | 21.6M $ | 1.88 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Large Cap Index Fund Fidelity Concord Street Trust | 27,982 | 19.8M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| EQ/Loomis Sayles Growth Portfolio EQ Advisors Trust | 27,748 | 21.4M $ | 2.80 % | as of Mar 31, 2026 ↗ |
| JPMorgan Hedged Equity Laddered Overlay ETF J.P. Morgan Exchange-Traded Fund Trust | 27,715 | 19.6M $ | 0.49 % | as of Apr 30, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 27,484 | 21.2M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| BALANCED PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 27,237 | 21M $ | 0.58 % | as of Mar 31, 2026 ↗ |
| Distillate U.S. Fundamental Stability & Value ETF ETF Series Solutions | 27,189 | 21M $ | 1.17 % | as of Mar 31, 2026 ↗ |
| AQR Equity Market Neutral Fund AQR Funds | 27,162 | 21M $ | 0.63 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 27,021 | 21.1M $ | 0.10 % | as of Feb 28, 2026 ↗ |
| Putnam Dynamic Asset Allocation Growth Fund Putnam Asset Allocation Funds | 26,788 | 20.7M $ | 0.54 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Large Company Index Fund SCHWAB CAPITAL TRUST | 26,770 | 18.9M $ | 0.15 % | as of Apr 30, 2026 ↗ |
| Invesco Large Cap Value ETF Invesco Exchange-Traded Fund Trust | 26,177 | 18.5M $ | 1.25 % | as of Apr 30, 2026 ↗ |
| Empower Large Cap Value Fund EMPOWER FUNDS, INC. | 25,920 | 20M $ | 0.97 % | as of Mar 31, 2026 ↗ |
| VOYA LARGE CAP VALUE FUND Voya Equity Trust | 25,918 | 20.3M $ | 1.25 % | as of Feb 28, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 25,591 | 19.8M $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI U.S. Large Cap Index Fund Fidelity Salem Street Trust | 25,525 | 18M $ | 0.12 % | as of Apr 30, 2026 ↗ |
| Invesco Summit Fund AIM Equity Funds (Invesco Equity Funds) | 25,470 | 18M $ | 0.51 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1000 ETF Invesco Exchange-Traded Fund Trust | 25,277 | 17.9M $ | 0.19 % | as of Apr 30, 2026 ↗ |
| Nuveen Multi Cap Value Fund Nuveen Investment Trust | 25,092 | 19.4M $ | 1.83 % | as of Mar 31, 2026 ↗ |
| MassMutual Blue Chip Growth Fund MASSMUTUAL SELECT FUNDS | 25,046 | 19.4M $ | 1.08 % | as of Mar 31, 2026 ↗ |
| Putnam Global Health Care Fund Putnam Global Health Care Fund | 25,018 | 19.6M $ | 1.23 % | as of Feb 28, 2026 ↗ |
| iShares ESG Aware MSCI USA ETF iShares Trust | 24,934 | 19.5M $ | 0.12 % | as of Feb 28, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 24,491 | 17.3M $ | 1.98 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 24,460 | 180M SEK | 0.12 % | as of Mar 31, 2026 ↗ |
| AB Relative Value Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 24,395 | 18.8M $ | 1.81 % | as of Mar 31, 2026 ↗ |
| Victory 500 Index Fund Victory Portfolios III | 24,241 | 17.1M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 24,049 | 18.8M $ | 0.21 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 23,991 | 18.8M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 23,991 | 18.5M $ | 0.36 % | as of Mar 31, 2026 ↗ |
| Variable Portfolio - Partners Core Equity Fund Columbia Funds Variable Series Trust II | 23,845 | 18.4M $ | 0.90 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.55 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 7.51 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.21 % | as of Mar 31, 2026 ↗ |
| Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust | 6.77 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6.03 % | as of Feb 28, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 5.46 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Global Fund Longleaf Partners Funds Trust | 4.83 % | as of Mar 31, 2026 ↗ |
| Longleaf Partners Fund Longleaf Partners Funds Trust | 4.82 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.77 % | as of Apr 30, 2026 ↗ |
| LIVE OAK HEALTH SCIENCES FUND Oak Associates Funds | 4.66 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,017 | +69 | 40,397,822 | +6.2 % |
| 2026Q1 | 948 | +29 | 38,042,108 | +7.4 % |
| 2025Q4 | 919 | +31 | 35,427,572 | -7.9 % |
| 2025Q3 | 888 | -76 | 38,464,142 | -8.2 % |
| 2025Q2 | 964 | +29 | 41,897,672 | -1.9 % |
| 2025Q1 | 935 | -91 | 42,717,919 | -8.6 % |
| 2024Q4 | 1,026 | -2 | 46,741,888 | -1.0 % |
| 2024Q3 | 1,028 | +4 | 47,228,499 | +0.0 % |
| 2024Q2 | 1,024 | +25 | 47,204,916 | +4.4 % |
| 2024Q1 | 999 | +5 | 45,210,158 | -5.5 % |
| 2023Q4 | 994 | 47,828,710 |
Institutional managers
1,377 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 8,947,735 | 6.9B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,664,478 | 3.6B $ | as of Mar 31, 2026 |
| Dodge & Cox | 4,458,238 | 3.4B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 4,311,806 | 3.2B $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,722,071 | 2.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,607,732 | 2B $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,177,527 | 1.7M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,065,064 | 1.6B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 1,912,310 | 1.5B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,837,459 | 1.4B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,724,478 | 1.3B $ | as of Mar 31, 2026 |
| FMR LLC | 1,518,192 | 1.2B $ | as of Mar 31, 2026 |
| Capital World Investors | 1,419,000 | 1.1B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,319,329 | 1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,300,558 | 1B $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 1,231,008 | 946M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,189,584 | 919.1M $ | as of Mar 31, 2026 |
| Amundi | 1,009,798 | 780.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 941,941 | 727.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 812,236 | 627.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 804,508 | 621.6M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 765,411 | 591.4M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 732,054 | 565.6M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 723,621 | 559.1M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 625,388 | 483.2M $ | as of Mar 31, 2026 |
Declared shareholders of Regeneron Pharmaceuticals, Inc.
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.37 % | 7,660,810 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Regeneron Pharmaceuticals, Inc.
130 funds declare 156 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Regeneron Pharmaceuticals, Inc.". https://titelia.com/en/stocks/regeneron-pharmaceuticals-inc-US75886F1075